Frank Booth made CMO as Sangart expands leadership team
This article was originally published in Scrip
Executive Summary
Sangart, a privately-held biopharmaceutical company focused on oxygen-therapeutics agents, has appointed three new members to its executive team, including Frank Booth who has been named chief medical officer. Mr Booth has over 20 years' experience as a trauma and critical care surgeon and as a clinical investigator. Previously he worked in clinical development roles at Novo Nordisk and Lilly.